Free tool
Diagnostics stocks
We cover 39 companies grouped under the Diagnostics theme. The median market value in the group is $26.94M. Across the group, the median move over the past trading day is 0.00%. 42% of the 38 with a 200-day average trade above it. Price change over the past year runs from −72.3% to +17.1% across the middle 80 percent of the group, with a median of −15.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
39 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 0KSX.L | Quest Diagnostics Incorporated | $244.75 | +0.90% | +43.04% | +39.19% |
| 0JSY.L | Labcorp Holdings Inc. | $336.52 | +0.57% | +33.89% | +23.27% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +7.58% | +17.51% | +12.65% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| BIM.PA | bioMérieux S.A. | 75.50 EUR | +3.64% | −31.05% | −35.91% |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| BIOPOR.CO | BioPorto A/S | 1.24 DKK | +2.48% | +19.00% | −3.13% |
| 7V0.DE | Novogenia AG | 6.40 EUR | +7.56% | −16.34% | −25.00% |
| ALKLH.PA | Klea Holding SA | 0.15 EUR | −4.73% | −31.24% | −32.00% |
| BIOBV.HE | Biohit Oyj | 2.60 EUR | −6.14% | −27.78% | −8.13% |
| 0DRP.L | Biohit Oyj | 2.60 EUR | −5.63% | −6.31% | −6.31% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.40 EUR | −2.44% | −37.50% | −46.67% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +16.21% | +21.19% | +7.38% |
| NCYT.L | Novacyt S.A. | 43.50 GBP | +17.73% | +21.00% | +7.81% |
| ABDX.L | Abingdon Health Plc | 10.75 GBP | +4.88% | +67.97% | +104.76% |
| ACARIX.ST | Acarix AB (publ) | 0.24 SEK | −3.99% | −10.93% | −14.11% |
| GDR.L | genedrive plc | 1.30 GBP | +33.33% | +48.57% | +67.74% |
| NN6.DE | NanoRepro AG | 1.85 EUR | −5.38% | +19.81% | −4.90% |
| ALIKO.PA | Ikonisys S.A. | 1.42 EUR | −5.33% | −12.07% | −6.58% |
| RENX.L | Renalytix Plc | 4.30 GBP | +62.26% | −27.12% | −26.50% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −79.17% |
| ALBIO.PA | Biosynex SA | 0.90 EUR | −0.88% | +56.06% | −23.23% |
| URT.WA | Urteste S.A. | 43.70 PLN | −6.42% | +2.82% | −15.31% |
| GMT.WA | Genomtec S.A. | 3.68 PLN | −8.80% | −2.39% | −40.65% |
| BIOVIC-B.ST | Biovica International AB (publ) | 0.45 SEK | −9.46% | +4.41% | −30.12% |
| BACTIQ.CO | BactiQuant A/S | 2.32 DKK | −0.43% | −37.47% | −10.42% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.19 SEK | −12.36% | −39.58% | −47.36% |
| CRM.WA | PZ Cormay S.A. | 0.52 PLN | 0.00% | +27.32% | +3.16% |
| BMX.WA | BioMaxima S.A. | 10.14 PLN | +1.71% | −17.89% | −20.78% |
| GENI.L | GENinCode Plc | 0.90 GBP | +12.50% | −62.50% | −35.71% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.61 SEK | +16.48% | −81.26% | −88.08% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | 1.50 GBP | −26.83% | −3.23% | +7.14% |
| VRCI.L | Verici Dx plc | 0.23 GBP | −35.71% | −68.97% | −57.14% |
| OBD.L | Oxford BioDynamics Plc | 0.12 GBP | −1.60% | −50.80% | −74.11% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| ALPRE.PA | Predilife S.A. | 1.11 EUR | −7.50% | −64.98% | −65.74% |
| 2CUREX.ST | 2cureX AB (publ) | 0.66 SEK | −62.67% | +22.68% | −71.79% |
| 0G8X.L | Immunovia AB (publ) | 0.15 SEK | −11.14% | −33.92% | −78.96% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.